{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:30:41Z","timestamp":1792740641718,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.3109\/14653249.2011.575356","type":"journal-article","created":{"date-parts":[[2011,5,4]],"date-time":"2011-05-04T07:48:17Z","timestamp":1304495297000},"page":"976-986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein\u2013Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation"],"prefix":"10.1016","volume":"13","author":[{"given":"Patrick J.","family":"Hanley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald R.","family":"Shaffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad R.Y.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Tzou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Demmler-Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen E.","family":"Heslop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clio M.","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine M.","family":"Bollard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3109\/14653249.2011.575356_bib0005","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1182\/blood.V99.12.4357","article-title":"High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution","volume":"99","author":"Chakrabarti","year":"2002","journal-title":"Blood"},{"key":"10.3109\/14653249.2011.575356_bib0010","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1182\/blood-2002-02-0377","article-title":"Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery","volume":"100","author":"Chakrabarti","year":"2002","journal-title":"Blood"},{"key":"10.3109\/14653249.2011.575356_bib0015","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.3109\/14653249.2011.575356_bib0020","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.bbmt.2008.07.014","article-title":"Expansion of cytomegalovirus pp65 and IE-1 specific cytotoxic T lymphocytes for cytomegalovirus-specific immunotherapy following allogeneic stem cell transplantation","volume":"14","author":"Bao","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.3109\/14653249.2011.575356_bib0025","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1128\/CMR.12.2.286","article-title":"Resistance of human cytomegalovirus to antiviral drugs","volume":"12","author":"Erice","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.3109\/14653249.2011.575356_bib0030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1034\/j.1399-3062.2001.003003177.x","article-title":"Epstein\u2013Barr virus post-transplant lymphoproliferative disease and virus-specific therapy: pharmacological re-activation of viral target genes with arginine butyrate","volume":"3","author":"Mentzer","year":"2001","journal-title":"Transpl Infect Dis"},{"key":"10.3109\/14653249.2011.575356_bib0035","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1182\/blood-2010-04-259291","article-title":"How I treat adenovirus in haematopoietic stem cell transplantation recipients","volume":"116","author":"Lindemans","year":"2010","journal-title":"Blood"},{"key":"10.3109\/14653249.2011.575356_bib0040","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"Leen","year":"2006","journal-title":"Nat Med"},{"key":"10.3109\/14653249.2011.575356_bib0045","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1352912","article-title":"Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"key":"10.3109\/14653249.2011.575356_bib0050","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12026-007-0059-2","article-title":"Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants","volume":"38","author":"O'Reilly","year":"2007","journal-title":"Immunol Res"},{"key":"10.3109\/14653249.2011.575356_bib0055","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jmv.1890430119","article-title":"Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes","volume":"43","author":"Laughlin-Taylor","year":"1994","journal-title":"J Med Virol"},{"key":"10.3109\/14653249.2011.575356_bib0060","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1749-6632.1991.tb33450.x","article-title":"Development of a treatment regimen for human cytomegalovirus (CMV) infection in bone marrow transplantation recipients by adoptive transfer of donor-derived CMV-specific T cell clones expanded in vitro","volume":"636","author":"Greenberg","year":"1991","journal-title":"Ann NY Acad Sci"},{"key":"10.3109\/14653249.2011.575356_bib0065","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(03)14634-X","article-title":"Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines","volume":"362","author":"Peggs","year":"2003","journal-title":"Lancet"},{"key":"10.3109\/14653249.2011.575356_bib0070","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1084\/jem.20042384","article-title":"Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells","volume":"201","author":"Bunde","year":"2005","journal-title":"J Exp Med"},{"key":"10.3109\/14653249.2011.575356_bib0075","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1099\/vir.0.82686-0","article-title":"Processing and MHC class I presentation of human cytomegalovirus pp65-derived peptides persist despite gpUS2-11-mediated immune evasion","volume":"88","author":"Besold","year":"2007","journal-title":"J Gen Virol"},{"key":"10.3109\/14653249.2011.575356_bib0080","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/383720a0","article-title":"Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product","volume":"383","author":"Gilbert","year":"1996","journal-title":"Nature"},{"key":"10.3109\/14653249.2011.575356_bib0085","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3109\/14653240903505822","article-title":"Co-ordinated isolation of CD8+ and CD4+ T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy","volume":"12","author":"Zandvliet","year":"2010","journal-title":"Cytotherapy"},{"key":"10.3109\/14653249.2011.575356_bib0090","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1479-5876-5-17","article-title":"CMV pp65 and IE-1 T cell epitopes recognized by healthy subjects","volume":"5","author":"Slezak","year":"2007","journal-title":"J Transl Med"},{"key":"10.3109\/14653249.2011.575356_bib0095","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jcv.2005.09.019","article-title":"Antigen-specific T cell responses induced by Towne cytomegalovirus (CMV) vaccine in CMV-seronegative vaccine recipients","volume":"35","author":"Jacobson","year":"2006","journal-title":"J Clin Virol"},{"key":"10.3109\/14653249.2011.575356_bib0100","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1182\/blood-2009-09-242263","article-title":"Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation","volume":"115","author":"Micklethwaite","year":"2010","journal-title":"Blood"},{"key":"10.3109\/14653249.2011.575356_bib0105","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2009-07-232454","article-title":"Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation","volume":"114","author":"Leen","year":"2009","journal-title":"Blood"},{"key":"10.3109\/14653249.2011.575356_bib0110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00002371-200305000-00008","article-title":"Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy","volume":"26","author":"Sili","year":"2003","journal-title":"J Immunother"},{"key":"10.3109\/14653249.2011.575356_bib0115","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(95)91150-2","article-title":"Use of gene-modified virus-specific T lymphocytes to control Epstein\u2013Barr-virus-related lymphoproliferation","volume":"345","author":"Rooney","year":"1995","journal-title":"Lancet"},{"key":"10.3109\/14653249.2011.575356_bib0120","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.cji.0000211325.30525.84","article-title":"Contact-activated monocytes: efficient antigen presenting cells for the stimulation of antigen-specific T cells","volume":"30","author":"Leen","year":"2007","journal-title":"J Immunother"},{"key":"10.3109\/14653249.2011.575356_bib0125","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/1521-4141(200006)30:6<1676::AID-IMMU1676>3.0.CO;2-V","article-title":"Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides","volume":"30","author":"Kern","year":"2000","journal-title":"Eur J Immunol"},{"key":"10.3109\/14653249.2011.575356_bib0130","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/JVI.01689-07","article-title":"Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy","volume":"82","author":"Leen","year":"2008","journal-title":"J Virol"},{"key":"10.3109\/14653249.2011.575356_bib0135","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1093\/bioinformatics\/btl479","article-title":"Peptide length-based prediction of peptide-MHC class II binding","volume":"22","author":"Chang","year":"2006","journal-title":"Bioinformatics"},{"key":"10.3109\/14653249.2011.575356_bib0140","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1182\/blood-2009-03-213256","article-title":"Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes","volume":"114","author":"Hanley","year":"2009","journal-title":"Blood"},{"key":"10.3109\/14653249.2011.575356_bib0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneph.2009.207","article-title":"Cytomegalovirus prophylaxis: how long is enough?","volume":"6","author":"Kumar","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.3109\/14653249.2011.575356_bib0150","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1182\/blood.V90.6.2502","article-title":"Neutropenia in allogeneic marrow transplant recipients receiving ganciclovir for prevention of cytomegalovirus disease: risk factors and outcome","volume":"90","author":"Salzberger","year":"1997","journal-title":"Blood"},{"key":"10.3109\/14653249.2011.575356_bib0155","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood.V88.10.4063.bloodjournal88104063","article-title":"Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study","volume":"88","author":"Boeckh","year":"1996","journal-title":"Blood"},{"key":"10.3109\/14653249.2011.575356_bib0160","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1084\/jem.20040613","article-title":"Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers","volume":"202","author":"Cobbold","year":"2005","journal-title":"J Exp Med"},{"key":"10.3109\/14653249.2011.575356_bib0165","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/blood.V95.3.807.003k24_807_814","article-title":"Epstein\u2013Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells","volume":"95","author":"Gustafsson","year":"2000","journal-title":"Blood"},{"key":"10.3109\/14653249.2011.575356_bib0170","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1182\/blood-2008-06-161695","article-title":"Prophylactic infusion of cytomegalovirus-specific cytotoxic T lymphocytes stimulated with Ad5f35pp65 gene-modified dendritic cells after allogeneic hemopoietic stem cell transplantation","volume":"112","author":"Micklethwaite","year":"2008","journal-title":"Blood"},{"key":"10.3109\/14653249.2011.575356_bib0175","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","article-title":"Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy","volume":"99","author":"Einsele","year":"2002","journal-title":"Blood"},{"key":"10.3109\/14653249.2011.575356_bib0180","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor","volume":"333","author":"Walter","year":"1995","journal-title":"N Engl J Med"},{"key":"10.3109\/14653249.2011.575356_bib0185","doi-asserted-by":"crossref","first-page":"743","DOI":"10.3109\/14653241003709686","article-title":"Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience","volume":"12","author":"Cruz","year":"2010","journal-title":"Cytotherapy"},{"key":"10.3109\/14653249.2011.575356_bib0190","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1182\/blood-2009-08-239186","article-title":"Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients","volume":"115","author":"Heslop","year":"2010","journal-title":"Blood"},{"key":"10.3109\/14653249.2011.575356_bib0195","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1182\/blood.V97.4.835","article-title":"An Epstein\u2013Barr virus deletion mutant associated with fatal lymphoproliferative disease unresponsive to therapy with virus-specific CTLs","volume":"97","author":"Gottschalk","year":"2001","journal-title":"Blood"},{"key":"10.3109\/14653249.2011.575356_bib0200","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4049\/jimmunol.168.2.909","article-title":"Generation of EBV-specific CD4+ cytotoxic T cells from virus naive individuals","volume":"168","author":"Savoldo","year":"2002","journal-title":"J Immunol"},{"key":"10.3109\/14653249.2011.575356_bib0205","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00430-008-0082-5","article-title":"Dynamics of T cell memory in human cytomegalovirus infection","volume":"197","author":"Waller","year":"2008","journal-title":"Med Microbiol Immunol"},{"key":"10.3109\/14653249.2011.575356_bib0210","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.bbmt.2004.05.011","article-title":"A comparison of gene transfer and antigen-loaded dendritic cells for the generation of CD4+ and CD8+cytomegalovirus-specific T cells in HLA-A2 + and HLA-A2-donors","volume":"10","author":"Foster","year":"2004","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.3109\/14653249.2011.575356_bib0215","doi-asserted-by":"crossref","first-page":"8056","DOI":"10.1128\/jvi.68.12.8056-8063.1994","article-title":"CD4+ T cells are required to sustain CD8+ cytotoxic T-cell responses during chronic viral infection","volume":"68","author":"Matloubian","year":"1994","journal-title":"J Virol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324911705783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324911705783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:15:10Z","timestamp":1761430510000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324911705783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S1465324911705783"],"URL":"https:\/\/doi.org\/10.3109\/14653249.2011.575356","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein\u2013Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3109\/14653249.2011.575356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}